{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:53:12Z","timestamp":1794541992560,"version":"4.9.1"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Our group previously reported isatin-based hydrazones (ISB1-ISB6)\nwere further evaluated for their in vitro acetylcholine esterase, butylcholinestrase and cytotoxic\neffects on cancer cell lines. The compounds successfully suppressed AChE and BChE, with Ki\nvalues ranging from 1.06\u00b10.07 to 23.57\u00b11.64 nM for AChE and 15.31\u00b11.28 to 84.41\u00b18.04 nM\nfor BChE. However, the IC50 values of these compounds for AChE and BChE were found to be\nin the ranges of 1.45-25.51 nM and 16.38-92.90 nM, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Furthermore, to explore the anti-tumor potential of our newly synthesized compounds,\nwe conducted a cytotoxic MTT assay to assess their impact on two different cancer cell lines:\nMCF7 and A2780.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Discussion:<\/jats:title>\n                    <jats:p>Our findings highlight diverse cytotoxic profiles among the compounds. Specifically,\nISB2, ISB3, and ISB4 demonstrated potential cytotoxicity in the A2780 cell line, while ISB6\nexhibited significant cytotoxicity in the MCF7 cell line. This suggests that these compounds\nhave different effects on cancer cell types, indicating the need for further investigation into their\npotential applications in cancer therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Finally, molecular docking and dynamic study revealed that lead molecule ISB3\nprovides stability in the AChE and BChE protein-ligand complex.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734099359621250320073543","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T08:01:36Z","timestamp":1744099296000},"page":"267-281","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cholinesterase Inhibition and Anticancer Properties of [4-(Benzyloxy) phenyl]{Methylidene}hydrazinylidene]-1,3-dihydro-2H-Indol-2-ones Using Swiss Target-guided Prediction"],"prefix":"10.2174","volume":"22","author":[{"given":"Naseer","family":"Maliyakkal","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, College of Applied Medical Sciences, Khamis Mushait, King Khalid University,Abha, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Faculty of Science, Bartin University, 74100, Bartin,T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Tuzun","sequence":"additional","affiliation":[{"name":"Department of Plant and Animal Production, Sivas Technical Sciences Vocational School, Sivas Cumhuriyet University,58140, Sivas, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Menadi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Science, Tokat Gaziosmanpasa University, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Cacan","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Faculty of Science, Tokat Gaziosmanpasa University, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmy Appadath","family":"Beeran","sequence":"additional","affiliation":[{"name":"Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Bindra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Payyaula","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9513","DOI":"10.1039\/D3RA00526G","volume":"13","author":"Kumar S.","year":"2023","unstructured":"Kumar S.; Manoharan A.; J J.; Abdelgawad M.A.; Mahdi W.A.; Alshehri S.; Ghoneim M.M.; Pappachen L.K.; Zachariah S.M.; Aneesh T.P.; Mathew B.; Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation. RSC Advances  2023,13(14),9513-9529","journal-title":"RSC Advances"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"6167","DOI":"10.3390\/molecules28166167","volume":"28","author":"Manoharan A.","year":"2023","unstructured":"Manoharan A.; Oh J.M.; Benny F.; Kumar S.; Abdelgawad M.A.; Ghoneim M.M.; Shaker M.E.; El-Sherbiny M.; Almohaimeed H.M.; Gahtori P.; Kim H.; Mathew B.; Assembling a cinnamyl pharmacophore in the C3-position of substituted isatins via microwave-assisted synthesis: Development of a new class of monoamine oxidase-b inhibitors for the treatment of parkinson\u2019s disease. Molecules  2023,28(16),6167","journal-title":"Molecules"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e202204196","DOI":"10.1002\/slct.202204196","volume":"8","author":"K\u0131sa D.","year":"2023","unstructured":"K\u0131sa D.; Imamoglu R.; Genc N.; Taslimi P.; Kaya Z.; Taskin-Tok T.; HPLC analysis, phytochemical content, and biological effects of Centaurea kilae against some metabolic enzymes: In vitro and in silico studies. ChemistrySelect  2023,8(6),e202204196","journal-title":"ChemistrySelect"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e202300286","DOI":"10.1002\/slct.202300286","volume":"8","author":"Karimov A.","year":"2023","unstructured":"Karimov A.; Taslimi P.; Orujova A.; Mammadova K.; K\u0131sa D.; Farzaliyev V.; Sujayev A.; Sadeghian N.; Taskin-Tok T.; Alwasel S.; Gulcin I.; Design, synthesis, characterization and biological activities of novel S\u2010(Acyloxy)butyl\u2010N,N\u2010Diethyldithiocarbamate compounds. ChemistrySelect  2023,8(18),e202300286","journal-title":"ChemistrySelect"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"106513","DOI":"10.1016\/j.bioorg.2023.106513","volume":"135","author":"G\u00f6k Y.","year":"2023","unstructured":"G\u00f6k Y.; Taslimi P.; \u015een B.; Bal S.; Akta\u015f A.; Ayg\u00fcn M.; Sadeghi M.; G\u00fcl\u00e7in \u0130.; Design, synthesis, characterization, crystal structure, in silico studies, and inhibitory properties of the PEPPSI type Pd(II)NHC complexes bearing chloro\/fluorobenzyl group. Bioorg Chem  2023,135,106513","journal-title":"Bioorg Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e202300648","DOI":"10.1002\/slct.202300648","volume":"8","author":"Tariq Riaz M.","year":"2023","unstructured":"Tariq Riaz M.; Taslimi P.; Yaqub M.; al-Rashida M.; Alharthy R.D.; El-Gokha A.; Shafiq Z.; Functionalized Diazabenzo[a]anthracenediones: Regioselective multicomponent synthesis and biological and computational studies as potential cholinesterase inhibitors. ChemistrySelect  2023,8(22),e202300648","journal-title":"ChemistrySelect"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e202301158","DOI":"10.1002\/slct.202301158","volume":"8","author":"Tokal\u0131 F.S.","year":"2023","unstructured":"Tokal\u0131 F.S.; Taslimi P.; Sadeghi M.; \u015eenol H.; Synthesis and evaluation of Quinazolin\u20104(3H)\u2010one derivatives as multitarget metabolic enzyme inhibitors: A biochemistry\u2010oriented drug design. ChemistrySelect  2023,8(25),e202301158","journal-title":"ChemistrySelect"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1478-811X-7-20","volume":"7","author":"Resende R.R.","year":"2009","unstructured":"Resende R.R.; Adhikari A.; Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun Signal  2009,7(1),20","journal-title":"Cell Commun Signal"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"108352","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"Marucci G.","year":"2021","unstructured":"Marucci G.; Buccioni M.; Ben D.D.; Lambertucci C.; Volpini R.; Amenta F.; Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology  2021,190,108352","journal-title":"Neuropharmacology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1041610203008688","volume":"14","author":"Martin F.","year":"2002","unstructured":"Martin F.; A clinical overview of cholinesterase inhibitors in Alzheimer\u2019s disease. Int Psychogeriatr  2002,14(Suppl. 1),93-126","journal-title":"Int Psychogeriatr"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2174\/1381612825666191008103141","volume":"25","author":"Kabir M.T.","year":"2019","unstructured":"Kabir M.T.; Uddin M.S.; Begum M.M.; Thangapandiyan S.; Rahman M.S.; Aleya L.; Mathew B.; Ahmed M.; Barreto G.E.; Ashraf G.M.; Cholinesterase inhibitors for Alzheimer\u2019s disease: Multitargeting strategy based on anti-alzheimer\u2019s drugs repositioning. Curr Pharm Des  2019,25(33),3519-3535","journal-title":"Curr Pharm Des"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.pneurobio.2011.07.002","volume":"95","author":"Kuzirian M.S.","year":"2011","unstructured":"Kuzirian M.S.; Paradis S.; Emerging themes in GABAergic synapse development. Prog Neurobiol  2011,95(1),68-87","journal-title":"Prog Neurobiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/prac.18400190161","volume":"19","author":"Erdmann O.L.","year":"1840","unstructured":"Erdmann O.L.; Investigations into Indigo. J Prakt Chem  1840,19(1),321-362","journal-title":"J Prakt Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JPRI\/2018\/39708","volume":"21","author":"Ibrahim S.","year":"2018","unstructured":"Ibrahim S.; Elsaman T.; Cytotoxic and anticancer activities of indoline-2,3-dione (Isatin) and its derivatives. J Pharm Res Int  2018,21(2),1-19","journal-title":"J Pharm Res Int"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.23939\/chcht09.01.029","volume":"9","author":"Lelyukh M.","year":"2015","unstructured":"Lelyukh M.; Havrylyuk D.; Lesyk R.; Synthesis and anticancer activity of isatin, oxadiazole and 4-thiazolidinone based conjugates. Chem Chem Technol  2015,9(1),29-36","journal-title":"Chem Chem Technol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"16244","DOI":"10.1021\/acsomega.2c01470","volume":"7","author":"Kumar S.","year":"2022","unstructured":"Kumar S.; Nair A.S.; Abdelgawad M.A.; Mathew B.; Exploration of the detailed structure\u2013activity relationships of isatin and their isomers as monoamine oxidase inhibitors. ACS Omega  2022,7(19),16244-16259","journal-title":"ACS Omega"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1039\/C8MD00585K","volume":"10","author":"Varun V.","year":"2019","unstructured":"Varun V.; Sonam S.; Kakkar R.; Isatin and its derivatives: A survey of recent syntheses, reactions, and applications. MedChemComm  2019,10(3),351-368","journal-title":"MedChemComm"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1590\/S0103-50532001000300002","volume":"12","author":"Silva J.F.M.","year":"2001","unstructured":"Silva J.F.M.; Garden S.J.; Pinto A.C.; The chemistry of isatins: A review from 1975 to 1999. J Braz Chem Soc  2001,12(3),273-324","journal-title":"J Braz Chem Soc"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41598-024-51728-x","volume":"14","author":"Kumar S.","year":"2024","unstructured":"Kumar S.; Oh J.M.; Prabhakaran P.; Awasti A.; Kim H.; Mathew B.; Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect. Sci Rep  2024,14(1),1264","journal-title":"Sci Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11094-023-02867-4","volume":"57","author":"Nain S.","year":"2023","unstructured":"Nain S.; Mathur G.; Anthwal T.; Sharma S.; Paliwal S.; Synthesis, characterization, and antibacterial activity of new isatin derivatives. Pharm Chem J  2023,57(2),196-203","journal-title":"Pharm Chem J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/cbdd.12273","volume":"83","author":"Raj R.","year":"2014","unstructured":"Raj R.; Biot C.; Carr\u00e8re-Kremer S.; Kremer L.; Gu\u00e9rardel Y.; Gut J.; Rosenthal P.J.; Forge D.; Kumar V.; 7-chloroquinoline-isatin conjugates: Antimalarial, antitubercular, and cytotoxic evaluation. Chem Biol Drug Des  2014,83(5),622-629","journal-title":"Chem Biol Drug Des"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1039\/C2CP42539D","volume":"15","author":"Paul B.K.","year":"2013","unstructured":"Paul B.K.; Ray D.; Guchhait N.; Unraveling the binding interaction and kinetics of a prospective anti-HIV drug with a model transport protein: Results and challenges. Phys Chem Chem Phys  2013,15(4),1275-1287","journal-title":"Phys Chem Chem Phys"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cclet.2012.03.014","volume":"23","author":"Prakash C.R.","year":"2012","unstructured":"Prakash C.R.; Raja S.; Saravanan G.; Design and synthesis of 4-(1-(4-chlorobenzyl)-2,3-dioxoindolin-5-yl)-1-(4-substituted\/unsubstituted benzylidene) semicarbazide: Novel agents with analgesic, anti-inflammatory and ulcerogenic properties. Chin Chem Lett  2012,23(5),541-544","journal-title":"Chin Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1016\/j.bmc.2009.09.028","volume":"17","author":"Khan K.M.","year":"2009","unstructured":"Khan K.M.; Khan M.; Ali M.; Taha M.; Rasheed S.; Perveen S.; Choudhary M.I.; Synthesis of bis-Schiff bases of isatins and their antiglycation activity. Bioorg Med Chem  2009,17(22),7795-7801","journal-title":"Bioorg Med Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejmech.2009.12.035","volume":"45","author":"Andreani A.","year":"2010","unstructured":"Andreani A.; Burnelli S.; Granaiola M.; Leoni A.; Locatelli A.; Morigi R.; Rambaldi M.; Varoli L.; Cremonini M.A.; Placucci G.; Cervellati R.; Greco E.; New isatin derivatives with antioxidant activity. Eur J Med Chem  2010,45(4),1374-1378","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.1021\/om301157z","volume":"32","author":"Kumar K.","year":"2013","unstructured":"Kumar K.; Carr\u00e8re-Kremer S.; Kremer L.; Gu\u00e9rardel Y.; Biot C.; Kumar V.; 1 H -1,2,3-triazole-tethered isatin\u2013ferrocene and isatin\u2013ferrocenylchalcone conjugates: Synthesis and in vitro antitubercular evaluation. Organometallics  2013,32(20),5713-5719","journal-title":"Organometallics"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/12081720","volume":"12","author":"Jarrahpour A.","year":"2007","unstructured":"Jarrahpour A.; Khalili D.; De Clercq E.; Salmi C.; Brunel J.M.; Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives. Molecules  2007,12(8),1720-1730","journal-title":"Molecules"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bfopcu.2014.02.001","volume":"52","author":"Saravanan G.","year":"2014","unstructured":"Saravanan G.; Alagarsamy V.; Dineshkumar P.; Anticonvulsant activity of novel 1-(morpholinomethyl)-3-substituted isatin derivatives. Bull Fac Pharm Cairo Univ  2014,52(1),115-124","journal-title":"Bull Fac Pharm Cairo Univ"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ejmech.2018.11.008","volume":"162","author":"Thakur R.K.","year":"2019","unstructured":"Thakur R.K.; Joshi P.; Upadhyaya K.; Singh K.; Sharma G.; Shukla S.K.; Tripathi R.; Tripathi R.P.; Synthesis of isatin based N1-alkylated 3-\u03b2-C-glycoconjugated-oxopropylidene oxindoles as potent antiplasmodial agents. Eur J Med Chem  2019,162,448-454","journal-title":"Eur J Med Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.bmcl.2011.02.037","volume":"21","author":"Kang I.J.","year":"2011","unstructured":"Kang I.J.; Wang L.W.; Hsu T.A.; Yueh A.; Lee C.C.; Lee Y.C.; Lee C.Y.; Chao Y.S.; Shih S.R.; Chern J.H.; Isatin-\u03b2-thiosemicarbazones as potent herpes simplex virus inhibitors. Bioorg Med Chem Lett  2011,21(7),1948-1952","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-16-1247-3_51-1","author":"Gideon D.A.","year":"2022","unstructured":"Gideon D.A.; Annadurai P.; Nirusimhan V.; Parashar A.; James J.; Dhayabaran V.V.;  Handbook of Oxidative Stress in Cancer: Therapeutic Aspects  2022,1-25","journal-title":"Handbook of Oxidative Stress in Cancer: Therapeutic Aspects"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"627272","DOI":"10.3389\/fmolb.2020.627272","volume":"7","author":"Ferraz de Paiva R.E.","year":"2021","unstructured":"Ferraz de Paiva R.E.; Vieira E.G.; Rodrigues da Silva D.; Wegermann C.A.; Costa Ferreira A.M.; Anticancer compounds based on isatin-derivatives: Strategies to ameliorate selectivity and efficiency. Front Mol Biosci  2021,7,627272","journal-title":"Front Mol Biosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12032-024-02396-4","volume":"41","author":"Kemel H.","year":"2024","unstructured":"Kemel H.; Benguedouar L.; Boudjerda D.; Menadi S.; Cacan E.; Sifour M.; Phytochemical profiling, cytotoxic, anti-migration, and anti-angiogenic potential of phenolic-rich fraction from Peganum harmala: In vitro and in ovo studies. Med Oncol  2024,41(6),144","journal-title":"Med Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"115","DOI":"10.26650\/EurJBiol.2020.0035","volume":"79","author":"Berkel \u00c7.","year":"2020","unstructured":"Berkel \u00c7.; K\u00fc\u00e7\u00fck B.; Usta M.; Y\u0131lmaz E.; \u00c7a\u00e7an E.; The effect of Olaparib and Bortezomib combination treatment on ovarian cancer cell lines. Eur J Biol  2020,79(2),115-123","journal-title":"Eur J Biol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"17573","DOI":"10.1038\/s41598-020-74250-2","volume":"10","author":"Abu-Helalah M.","year":"2020","unstructured":"Abu-Helalah M.; Azab B.; Mubaidin R.; Ali D.; Jafar H.; Alshraideh H.; Drou N.; Awidi A.; BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan. Sci Rep  2020,10(1),17573","journal-title":"Sci Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"Swain S.M.","year":"2023","unstructured":"Swain S.M.; Shastry M.; Hamilton E.; Targeting HER2-positive breast cancer: Advances and future directions. Nat Rev Drug Discov  2023,22(2),101-126","journal-title":"Nat Rev Drug Discov"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/B978-0-12-815960-6.00026-1","author":"Dasgupta A.","year":"2021","unstructured":"Dasgupta A.; Wahed A.; Tumor markers. Clinical Chemistry, Immunology and Laboratory Quality Control  2021,269-293","journal-title":"Clinical Chemistry, Immunology and Laboratory Quality Control"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"103579","DOI":"10.1016\/j.mod.2019.103579","volume":"160","author":"Ribatti D.","year":"2019","unstructured":"Ribatti D.; The discovery of the fundamental role of VEGF in the development of the vascular system. Mech Dev  2019,160,103579","journal-title":"Mech Dev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1038\/s41467-021-27210-x","volume":"12","author":"Lv D.","year":"2021","unstructured":"Lv D.; Pal P.; Liu X.; Jia Y.; Thummuri D.; Zhang P.; Hu W.; Pei J.; Zhang Q.; Zhou S.; Khan S.; Zhang X.; Hua N.; Yang Q.; Arango S.; Zhang W.; Nayak D.; Olsen S.K.; Weintraub S.T.; Hromas R.; Konopleva M.; Yuan Y.; Zheng G.; Zhou D.; Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun  2021,12(1),6896","journal-title":"Nat Commun"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41418-021-00823-x","volume":"28","author":"Uxa S.","year":"2021","unstructured":"Uxa S.; Castillo-Binder P.; Kohler R.; Stangner K.; M\u00fcller G.A.; Engeland K.; Ki-67 gene expression. Cell Death Differ  2021,28(12),3357-3370","journal-title":"Cell Death Differ"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"Daina A.","year":"2019","unstructured":"Daina A.; Michielin O.; Zoete V.; Swisstargetprediction: Updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res  2019,47(W1),W357-W364","journal-title":"Nucleic Acids Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"35240","DOI":"10.1039\/D3RA07035B","volume":"13","author":"Benny F.","year":"2023","unstructured":"Benny F.; Oh J.M.; Kumar S.; Abdelgawad M.A.; Ghoneim M.M.; Abdel-Bakky M.S.; Kukerti N.; Jose J.; Kim H.; Mathew B.; Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment. RSC Advances  2023,13(50),35240-35250","journal-title":"RSC Advances"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"Ellman G.L.","year":"1961","unstructured":"Ellman G.L.; Courtney K.D.; Andres V.; Featherstone R.M.; A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol  1961,7(2),88-95","journal-title":"Biochem Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1038\/s41598-024-55628-y","volume":"14","author":"Kumar S.","year":"2024","unstructured":"Kumar S.; Bhowmik R.; Oh J.M.; Abdelgawad M.A.; Ghoneim M.M.; Al-Serwi R.H.; Kim H.; Mathew B.; Machine learning driven web-based app platform for the discovery of monoamine oxidase B inhibitors. Sci Rep  2024,14(1),4868","journal-title":"Sci Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/cbin.11352","volume":"44","author":"Berkel C.","year":"2020","unstructured":"Berkel C.; Cacan E.; In silico analysis of DYNLL1 expression in ovarian cancer chemoresistance. Cell Biol Int  2020,44(8),1598-1605","journal-title":"Cell Biol Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/1120009X.2020.1740389","volume":"32","author":"Cacan E.","year":"2020","unstructured":"Cacan E.; Ozmen Z.C.; Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells. J Chemother  2020,32(4),193-201","journal-title":"J Chemother"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"108193","DOI":"10.1016\/j.inoche.2020.108193","volume":"121","author":"Al-Janabi A.S.M.","year":"2020","unstructured":"Al-Janabi A.S.M.; Alheety M.A.; Al-Samrai O.A.Y.; Shaaban S.; Kibar B.; Cacan E.; Anti-cancer and anti-fungal evaluation of novel palladium(II) 1-phenyl-1H-tetrazol-5-thiol complexes. Inorg Chem Commun  2020,121,108193","journal-title":"Inorg Chem Commun"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/ml400304w","volume":"4","author":"Cheung J.","year":"2013","unstructured":"Cheung J.; Gary E.N.; Shiomi K.; Rosenberry T.L.; Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility. ACS Med Chem Lett  2013,4(11),1091-1096","journal-title":"ACS Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"Nachon F.","year":"2013","unstructured":"Nachon F.; Carletti E.; Ronco C.; Trovaslet M.; Nicolet Y.; Jean L.; Renard P.Y.; Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl- and butyryl-cholinesterase. Biochem J  2013,453(3),393-399","journal-title":"Biochem J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/07391102.2023.2214216","volume":"42","author":"Kumar S.","year":"2024","unstructured":"Kumar S.; Jayan J.; Manoharan A.; Benny F.; Abdelgawad M.A.; Ghoneim M.M.; El-Sherbiny M.; Thazhathuveedu Sudevan S.; Aneesh T.P.; Mathew B.; Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation. J Biomol Struct Dyn  2024,42(5),2328-2340","journal-title":"J Biomol Struct Dyn"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.1021\/acsomega.2c00397","volume":"7","author":"Mathew B.","year":"2022","unstructured":"Mathew B.; Oh J.M.; Abdelgawad M.A.; Khames A.; Ghoneim M.M.; Kumar S.; Nath L.R.; Sudevan S.T.; Parambi D.G.T.; Agoni C.; Soliman M.E.S.; Kim H.; Conjugated dienones from differently substituted cinnamaldehyde as highly potent monoamine oxidase-b inhibitors: Synthesis, biochemistry, and computational chemistry. ACS Omega  2022,7(9),8184-8197","journal-title":"ACS Omega"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"140503","DOI":"10.1016\/j.molstruc.2024.140503","volume":"1322","author":"Thomas R.R.","year":"2025","unstructured":"Thomas R.R.; Trisciuzzi D.; Sudevan S.T.; Gambacorta N.; Catto M.; Kumar S.; Abdelgawad M.A.; El-Ghorab A.H.; Selim S.; Ghoneim M.M.; Zachariah S.M.; Nicolotti O.; Mathew B.; Isatin derived morpholine and piperazine derivatives as acetylcholinesterase inhibitors. J Mol Struct  2025,1322,140503","journal-title":"J Mol Struct"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/978-3-030-62059-2_418","author":"Sridhar G.R.","year":"2022","unstructured":"Sridhar G.R.; Acetylcholinesterase inhibitors (galantamine, rivastigmine, and donepezil). NeuroPsychopharmacotherapy  2022,2709-2721","journal-title":"NeuroPsychopharmacotherapy"},{"key":"ref=54","first-page":"119","author":"Ayd\u0131n G.","year":"2012","unstructured":"Ayd\u0131n G.; Ercan A.; Gene expression levels of apoptotic proteins and multidrug resistance genes in HEPG2 cells. Hacettepe Univ J Fac Pharm  2012(2),119-132","journal-title":"Hacettepe Univ J Fac Pharm"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099359621250320073543","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240770\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099359621250320073543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:14:50Z","timestamp":1785989690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240770\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734099359621250320073543","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-10-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}